A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

PF-07220060 + PF-07104091 combination dose escalationOngoingActive not recruitingPhase 1Open NCT05262400 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT05262400 · Trial Tracker · ComplyRx